Cipta Sarana Medika Tbk. vs Lippo Cikarang Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Lippo Cikarang Tbk trades at Rp510 (market cap 2.59T, 832K 24h volume). The key difference: Lippo Cikarang Tbk is far larger — about 16.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 832K). Which is the better fit depends on your goals.
| DKHH | LPCK | |
|---|---|---|
Market Cap | 158.12B | 2.59T |
Volume | 8.21M | 832K |
Lot | 82.15K | 8.32K |
Turnover | 515.2M | 421.88M |
Average Price | 62.72 | 507.07 |
Value | 515.2M | 421.88M |
Indicative Equilibrium Price | 63 | 510 |
Indicative Equilibrium Volume | 1.33K | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Lippo Cikarang Tbk was established in the Republic of Indonesia the framework of the Domestic Capital Investment Law on July 20, 1987 based on Notarial Deed No.43 of Hendra Karyadi, S.H., as amended by Notarial Deed No. 63 of the same notary dated April 22, 1998.
Read more on LPCK →